Waiting
Login-Verarbeitung ...

Trial ends in Request Full Access Tell Your Colleague About Jove
Journal / Medicine / Induction of Nephrotic Syndrome in Mice by…
JoVE Journal
Medicine

Ein Abonnement für JoVE ist erforderlich, um diesen Inhalt ansehen zu können. Melden Sie sich an oder starten Sie Ihre kostenlose Testversion.

JoVE Journal Medicine
Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin
 

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin

Article DOI: 10.3791/57642-v • 07:38 min • May 6th, 2018
May 6th, 2018 •
1,2,3, 1,2,3
1Department of Internal Medicine, Division of Endocrinology, Diabetology, Vascular Disease, Nephrology and Clinical Chemistry, University Hospital Tübingen, 2Institute of Diabetes Research and Metabolic Diseases (IDM) of the Helmholtz Center Munich, University Tübingen, 3German Center for Diabetes Research (DZD), University Tübingen

Kapitel

Summary
Automatic Translation

Here, we describe the induction of experimental nephrotic syndrome in 129S1/SvImJ mice by rapid retrobulbar injection of doxorubicin. We also treat nephrotic mice with sustained release pellets containing aprotinin to inhibit urinary serine protease activity and prevent sodium retention.

Tags

Mouse Model Nephrotic Syndrome Doxorubicin Retrobulbar Injection Sodium Retention Edema Formation Proteasuria Proteases Urine Chronic Kidney Disease Implantation Segment Research Fellow Injection Syringe Doxorubicin Dose Volume Confirmation Anesthesia Lateral Recumbency Eyeball Protrusion
Read Article

Get cutting-edge science videos from JoVE sent straight to your inbox every month.

Waiting X
Simple Hit Counter